Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Pearce

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Toxicon : Official Journal of the International Society on Toxinology|December 24, 1997
Pharmacologic characterization of botulinum toxin for basic science and medicineL B Pearce, E R First, R D MacCallum, et al.
Toxicology and Applied Pharmacology|September 1, 1994
Measurement of botulinum toxin activity: evaluation of the lethality assayL B Pearce, G E Borodic, E R First, et al.
Biochemical Pharmacology|May 1, 1981
Phenylhydrazine: selective inhibition of human brain type B monoamine oxidaseJ A Roth, B J Eddy, L B Pearce, et al.
Biochemical Pharmacology|July 1, 1987
Catecholamine-metabolizing enzyme activity in the nigrostriatal systemA Francis, R Whittemore, D R Jeffery, et al.
Ophthalmic Plastic and Reconstructive Surgery|January 1, 1993
Botulinum B toxin as an alternative to botulinum A toxin: a histologic studyG E Borodic, L B Pearce, K L Smith, et al.
Biochemistry|June 14, 1988
Two functionally distinct forms of guanosine cyclic 3',5'-phosphate stimulated cation channels in a bovine rod photoreceptor disk preparationL B Pearce, R D Calhoon, P R Burns, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 1, 1995
The median paralysis unit: a more pharmacologically relevant unit of biologic activity for botulinum toxinL B Pearce, G E Borodic, E A Johnson, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 21, 2015
Absence of developmental toxicity in a canine model after infusion of a hemoglobin-based oxygen carrier: Implications for risk assessmentJ F Holson, D G Stump, L B Pearce, et al.
Plastic and Reconstructive Surgery|May 1, 1993
Botulinum A toxin for treatment of aberrant facial nerve regenerationG E Borodic, L B Pearce, M Cheney, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 25, 2015
Developmental toxicity in rats of a hemoglobin-based oxygen carrier results from impeded function of the inverted visceral yolk sacD G Stump, J F Holson, C Harris, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Toxicon : Official Journal of the International Society on Toxinology|December 24, 1997
Pharmacologic characterization of botulinum toxin for basic science and medicineL B Pearce, E R First, R D MacCallum, et al.
Toxicology and Applied Pharmacology|September 1, 1994
Measurement of botulinum toxin activity: evaluation of the lethality assayL B Pearce, G E Borodic, E R First, et al.
Biochemical Pharmacology|May 1, 1981
Phenylhydrazine: selective inhibition of human brain type B monoamine oxidaseJ A Roth, B J Eddy, L B Pearce, et al.
Biochemical Pharmacology|July 1, 1987
Catecholamine-metabolizing enzyme activity in the nigrostriatal systemA Francis, R Whittemore, D R Jeffery, et al.
Ophthalmic Plastic and Reconstructive Surgery|January 1, 1993
Botulinum B toxin as an alternative to botulinum A toxin: a histologic studyG E Borodic, L B Pearce, K L Smith, et al.
Biochemistry|June 14, 1988
Two functionally distinct forms of guanosine cyclic 3',5'-phosphate stimulated cation channels in a bovine rod photoreceptor disk preparationL B Pearce, R D Calhoon, P R Burns, et al.
Toxicon : Official Journal of the International Society on Toxinology|February 1, 1995
The median paralysis unit: a more pharmacologically relevant unit of biologic activity for botulinum toxinL B Pearce, G E Borodic, E A Johnson, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 21, 2015
Absence of developmental toxicity in a canine model after infusion of a hemoglobin-based oxygen carrier: Implications for risk assessmentJ F Holson, D G Stump, L B Pearce, et al.
Plastic and Reconstructive Surgery|May 1, 1993
Botulinum A toxin for treatment of aberrant facial nerve regenerationG E Borodic, L B Pearce, M Cheney, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 25, 2015
Developmental toxicity in rats of a hemoglobin-based oxygen carrier results from impeded function of the inverted visceral yolk sacD G Stump, J F Holson, C Harris, et al.
Pageof 4